Meeting
2019 Gastrointestinal Cancers Symposium
Comparison of adjuvant chemotherapy, chemoradiation, and chemotherapy followed by chemoradiation for resected stage I-II pancreatic cancer.
Authors
Sung Jun Ma
Roswell Park Comprehensive Cancer Center, Buffalo, NY
Sung Jun Ma , Gregory Hermann , Kavitha M Prezzano , Lucas M Serra , Austin J Iovoli , Anurag K Singh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 372)
DOI
10.1200/JCO.2019.37.4_suppl.372
Abstract #
372
Poster Bd #
K12
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Adjuvant concurrent chemoradiotherapy in extrahepatic cholangiocarcinoma.
First Author: Walid Labib Shaib
Poster
2017 ASCO Annual Meeting
Selective benefit of adjuvant chemoradiation in resectable pancreatic cancer.
First Author: Jesse P Wright
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Vascular resection for pancreas cancer: Ten-year real-world experience from a single high-volume center.
First Author: David Henault
Poster
2023 ASCO Annual Meeting
Radiotherapy alone versus concurrent or adjuvant chemoradiotherapy for nasopharyngeal carcinoma patients with negative Epstein-Barr virus DNA post-induction chemotherapy.
First Author: Fang-Fang Kong